A primer on ECG measurement precision and why it matters
The importance of accurate ECG measurement
Written by:
- Robert Kleiman, M.D. – Chief Science and Regulatory Advisor, Cardiac Safety at Clario, part of Thermo Fisher Scientific
Summary
This white paper reviews the evolution of ECG measurement technology, explains how precision affects QT/QTc analysis, and explores why increasingly accurate ECG measurements are enabling more efficient cardiac safety strategies in drug development.
The QTc interval remains a cornerstone of cardiac safety assessment
Following the withdrawal of multiple drugs associated with QT prolongation and Torsades de Pointes, regulatory guidance established QTc monitoring as a primary surrogate marker for proarrhythmic risk. Today, precise assessment of QTc effects is central to evaluating the cardiac safety profile of investigational therapies.
Measurement precision has improved dramatically
Traditional manual ECG measurements performed on paper tracings were limited by the resolution of printed ECGs and measurement tools, resulting in QTc precision of approximately 10 to 12 milliseconds. Advances in digital ECG acquisition, centralized ECG analysis, and semi-automated adjudication methodologies have reduced within-subject variability to approximately 5 to 6 milliseconds.
Better precision reduces variability and strengthens confidence
Improved QTc measurement precision narrows confidence intervals around estimated drug effects, increasing the ability to confidently exclude clinically meaningful QT prolongation. While precision gains have modestly reduced sample sizes for traditional Thorough QT (TQT) studies, they significantly enhance the reliability of cardiac safety conclusions.
Precision enables more efficient clinical development strategies
The 2015 revision of ICH E14 introduced concentration-effect modeling (CEM) as an accepted approach for QT assessment. With highly precise ECG data, sponsors may be able to leverage ECG assessments collected during Phase I SAD and MAD studies rather than conducting separate dedicated TQT trials, potentially reducing development timelines and costs by millions of dollars.
Early Precision QT Analysis further advances cardiac safety evaluation
Enhanced approaches such as Early Precision QT Analysis (EPQT) increase the number of analyzed beats and ECG replicates at each timepoint, generating richer datasets and improving measurement precision. These methods support robust concentration-QTc analyses and help maximize the value of early-phase clinical studies.
Why it matters
01
Strategic advantage
High-quality ECG analysis supports regulatory-grade cardiac safety assessments, improves statistical power, and increases the likelihood that early-phase studies can provide the evidence needed to replace dedicated TQT trials.
02
Efficiently demonstrate cardiac safety
Early precision QT analysis delivers a more efficient pathway to demonstrating cardiac safety while reducing study complexity, timelines, and overall development costs.
Explore the full white paper
Get the complete white paper today or click get started to continue the conversation.
FAQs
What is ECG measurement precision?
ECG measurement precision refers to the consistency and reproducibility of interval duration measurements such as QT, QTc, PR, and QRS intervals. Higher precision reduces measurement variability, allowing researchers to detect small drug-related cardiac effects with greater confidence.
What factors affect QTc measurement precision?
QTc measurements can be influenced by physiologic variability, heart rate changes, ECG signal quality, T-wave morphology, meal timing, electrolyte fluctuations, medications, and measurement methodology. Advanced digital ECG technologies and centralized analysis processes help minimize these sources of variation.
How does ECG precision affect Thorough QT (TQT) studies?
More precise QTc measurements reduce variability and improve statistical power, helping sponsors demonstrate the absence of clinically meaningful QT prolongation with greater confidence. Improved precision has also contributed to reductions in TQT study sample sizes over time.
What is concentration-effect modeling (CEM)?
Concentration-effect modeling is a statistical approach that evaluates the relationship between drug concentration and QTc change across all available study data. Adopted as an accepted regulatory approach in the revised ICH E14 guidance, CEM can reduce the need for dedicated TQT studies when appropriate data are collected during early-phase trials.
